Metraipolis › archive › dc_7e378c9c3dca
Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions — Europe PMC PMID:42449597
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42449597
- DOI
- 10.3390/cancers18132051
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T05:04:38.763Z
- SHA-256 of the archived text
a86cf1695cb7861c8749f288d5cb4e9aa1d4f0fe99fd620f06dede204c057fae- Stable URL of this page
https://metraipolis.com/documento/dc_7e378c9c3dca
How to cite
Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions — Europe PMC PMID:42449597 — Europe PMC (en), https://europepmc.org/article/MED/42449597 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e378c9c3dca (Metraipolis archive dc_7e378c9c3dca, sha256 a86cf1695cb7861c8749f288d5cb4e9aa1d4f0fe99fd620f06dede204c057fae)
BibTeX
@misc{dc7e378c9c3dca,
title = {Chimeric Antigen Receptor-Immune Cell-Based Therapies for Clear Cell Renal Cell Carcinoma: Latest Advancements and Directions — Europe PMC PMID:42449597},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42449597},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e378c9c3dca; sha256 a86cf1695cb7861c8749f288d5cb4e9aa1d4f0fe99fd620f06dede204c057fae},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42449597. Agents can read the archived copy with the MCP tool read_document.